Emerging experimental models and small-scale clinical trials have shown promise of S1P modulator for the treatment of stroke (Cyster and Schwab, 2012; Kraft et al., 2013; Fu et al., 2014; Qin et al., 2017). The gene discussed is MBTPS1; the disease is Stroke.